BLOG

Scientists create artificial skin from stem cells derived from umbilical cord! – India.Com Health

Scientists create artificial skin from stem cells derived from umbilical cord!India.Com Healthstem cell In a major breakthrough, scientists have managed to grow artificial skin using stem cells derived from the umbilical cord. Scientists from the Tissue Engineering Research Group at the Department of Histology at the University of Granada … and more …read more   &nbs… Continue reading

2013-11-25 NEWS

Novogen’s drug destroys ovarian cancer stem cell tumours – Proactive Investors Australia

Proactive Investors AustraliaNovogen’s US subsidiary CanTx, in conjunction with Yale University, has shown that cancer stem cells isolated from the tumors of ovarian cancer patients are able to form self-renewing spheroids. When injected into a mouse model, these spheroids form …Trilexium Destroys Ovarian Cancer Stem Cell Spheroidsirasia.com (press release) all 2 news articles …read more   &nbs… Continue reading

2013-11-25 NEWS

Regeneus to fast track human stem cell osteoarthritis therapies in Japan – Proactive Investors Australia

Regeneus to fast track human stem cell osteoarthritis therapies in JapanProactive Investors AustraliaChief executive officer Professor Graham Vesey added the Japanese law provided the company with a well-defined pathway to fast-track the clinical trial and potential approval of its new human off-the-shelf cell therapy to treat osteoarthritis and other … …read more   &nbs… Continue reading

2013-11-25 NEWS

New Japanese Regenerative Medicine Legislation and Commercial … – GlobeNewswire (press release)

GlobeNewswire (press release)25, 2013 (GLOBE NEWSWIRE) — Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today gave an update on new legislation which provides a framework for accelerated approval of stem cell products in Japan, the world’s …Mesoblast lifted by Japan stem cell plansCommBank MyWealth all 8 news articles …read more   &nbs… Continue reading

2013-11-25 NEWS

New Japanese Regenerative Medicine Legislation and Commercial … – Wall Street Journal

New Japanese Regenerative Medicine Legislation and Commercial …Wall Street Journal25, 2013 (GLOBE NEWSWIRE) — Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today gave an update on new legislation which provides a framework for accelerated approval of stem cell products in Japan, the world’s … and more …read more   &nbs… Continue reading

2013-11-25 NEWS